NAMSW vs. ATNFW, SXTPW, DRTSW, APLMW, ARTLW, BCDAW, BCTXW, CDIOW, CTCXW, and SAVAW
Should you be buying NewAmsterdam Pharma stock or one of its competitors? The main competitors of NewAmsterdam Pharma include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), Artelo Biosciences (ARTLW), BioCardia (BCDAW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), and Cassava Sciences (SAVAW). These companies are all part of the "biotechnology" industry.
NewAmsterdam Pharma (NASDAQ:NAMSW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, community ranking, earnings, analyst recommendations, institutional ownership, profitability, dividends, risk and media sentiment.
In the previous week, 180 Life Sciences had 1 more articles in the media than NewAmsterdam Pharma. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for NewAmsterdam Pharma. NewAmsterdam Pharma's average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.
NewAmsterdam Pharma and 180 Life Sciences both received 0 outperform votes by MarketBeat users.
Summary
NewAmsterdam Pharma and 180 Life Sciences tied by winning 1 of the 2 factors compared between the two stocks.
Get NewAmsterdam Pharma News Delivered to You Automatically
Sign up to receive the latest news and ratings for NAMSW and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
NAMSW vs. The Competition
NewAmsterdam Pharma Competitors List
Related Companies and Tools
